% | $
Quotes you view appear here for quick access.

Astex Pharmaceuticals, AŞ Message Board

  • thinkabout1120 thinkabout1120 Sep 28, 2012 11:35 AM Flag

    Unless and Untill

    Well, it seams that this company has confirmed that it is a “Johnny one note”
    Once again, I have to say since Manuso has taken charge; all they have to show for the tenure are big bounces and perks paid and the same drug they started with in the first place.
    You know it, I know it and the street knows it.

    We have all of the sounds of an empty drum from Manuso, with no new results.
    Unless and until they launch a new compound, nothing new in over a decade, we will have nuttin!
    Let us hope that they can launch a new compound soon.

    Sentiment: Hold

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Wrong, the street knows the have a worthless CEO, Man uso who is over paid for little or no performance. Until he gets booted, shareholders get screwed.

    • When FDA denied on AML, I figured EU would go the same way. Now I am surprised that approval didn't even spike volume. I could understand old hands selling into strength after the pre-decision run-up and keeping the price stagnant, but volume is acting as though nothing happened.

      At least we now have the J&J machine pushing this stuff in the EU. Orphan designation and a $5 mil milestone won't hurt either. Maybe a change in earnings will start share price appreciation.